Another Ineffective and Toxic Flu Drug Approved by FDA

The U.S. Food and Drug Administration (FDA) approved a new influenza drug called Rapivab (peramivir). Rapivab is given intravenously as a single dose in adults who have been symptomatic with the flu for no more than two days. This drug is in the neuraminidase family of drugs which includes Tamiflu and Relenza, which are oral medications. Folks, the U.S. Government gave almost $235 million dollars in grant money to study Rapivab. I think that money could be better spent studying the effects of vitamin C on the flu. At least vitamin C is not associated with serious side effects. I would avoid taking all neuraminidase inhibitors. They have little effectiveness. They are too expensive. And, they are associated with severe side effects. We don’t need another ineffective, expensive, and toxic flu drug on the market. I think we would be better off removing all of the neuraminidase inhibitors from the market.